This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Debiotech S.a.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations by Eric Chappel in Drug Delivery Systems
Introduction
Eric Chappel is an accomplished inventor based in Lausanne, Switzerland. He has made significant contributions to the field of medical devices, particularly in drug delivery systems. With a total of 2 patents, his work focuses on enhancing the efficiency and safety of drug administration.
Latest Patents
Chappel's latest patents include a novel drug delivery system designed to be securely attached to a patient's skin. This system features a first container with a variable volume and a second container that also has a variable volume. The design includes a skin adherable unit that ensures both containers remain in place on the patient's skin. Additionally, the system incorporates a containers' interface that allows for the operational coupling of the two containers, enabling a volume increase in one to induce a volume decrease in the other. To enhance safety, the system is equipped with a vent device that prevents unintended pressure increases in the first storage compartment. Another notable patent is a status indicator for the drug delivery system, which consists of one or several plungers within an elongated cavity. This indicator device provides users with information regarding the current status of the delivery system, featuring at least one movable element that reaches predetermined positions based on the system's status.
Career Highlights
Eric Chappel is currently employed at Debiotech S.A., a company known for its innovative medical technology solutions. His work at Debiotech has allowed him to focus on developing advanced drug delivery systems that improve patient care.
Collaborations
Chappel collaborates with talented professionals in his field, including Dimitry Dumont-Fillon and Arnaud Belladon. Their combined expertise contributes to the innovative projects at Debiotech.
Conclusion
Eric Chappel's contributions to drug delivery systems exemplify the importance of innovation in medical technology. His patents reflect a commitment to improving patient outcomes through advanced design and functionality.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile